Germline DNA copy number aberrations identified as potential prognostic factors for breast cancer recurrence.
Breast cancer recurrence (BCR) is a common treatment outcome despite curative-intent primary treatment of non-metastatic breast cancer. Currently used prognostic and predictive factors utilize tumor-based markers, and are not optimal determinants of risk of BCR. Germline-based copy number aberration...
Guardado en:
Autores principales: | Yadav Sapkota, Sunita Ghosh, Raymond Lai, Bradley P Coe, Carol E Cass, Yutaka Yasui, John R Mackey, Sambasivarao Damaraju |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2285fe0cfbbf425995582c081c331530 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Breast cancer associated germline structural variants harboring small noncoding RNAs impact post-transcriptional gene regulation
por: Mahalakshmi Kumaran, et al.
Publicado: (2018) -
Aberrant telomere length and mitochondrial DNA copy number in suicide completers
por: Ikuo Otsuka, et al.
Publicado: (2017) -
Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
por: David Brown, et al.
Publicado: (2017) -
The association between DNA copy number aberrations at chromosome 5q22 and gastric cancer.
por: Pei-Chien Tsai, et al.
Publicado: (2014) -
Accurate quantification of copy-number aberrations and whole-genome duplications in multi-sample tumor sequencing data
por: Simone Zaccaria, et al.
Publicado: (2020)